Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

TRACON Pharmaceuticals: Q4 Earnings Insights

TRACON Pharmaceuticals (NASDAQ:TCON) reported its Q4 earnings results on Tuesday, March 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
byBenzinga Insights
March 15, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

TRACON Pharmaceuticals (NASDAQ:TCON) reported its Q4 earnings results on Tuesday, March 15, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

TRACON Pharmaceuticals missed estimated earnings by 14.29%, reporting an EPS of $-0.4 versus an estimate of $-0.35.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.06 which was followed by a 1.37% drop in the share price the next day.

 

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Preview For Hercules Capital

By Benzinga Insights
Today, 2:26 AM
Hercules Capital (NYSE:HTGC) is set to give its latest quarterly earnings report on Thursday, 2022-07-28. Here's what investors need to know before the announcement. Analysts estimate that Hercules Capital will report an earnings per share (EPS) of $0.33.

HTGC